FindTrial
Sign In

A study to evaluate pharmacists education on hyperlipidemia patients

Impact of pharmacist’s Intervention on lipid profile in patients treated for dyslipidemia in a tertiary care hospital – A randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/12/030065
Enrollment
378
Registered
2020-12-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

Intervention1: Pharmacist Intervention: The intervention group will receive the standard care by the physician and educational intervention by a clinical pharmacist. (Educational intervention includes

Sponsors

Dr Ramesh Bhandari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Both obese as well as non-obese patients diagnosed with dyslipidemia or hyperlipidemia and on lipid-lowering therapy

Exclusion criteria

Exclusion criteria: Patients with secondary dyslipidemia (due to drugs). Patient diagnosed with terminally ill (life expectancy Subjects having untreated hyperthyroidism. Special population like pregnant and lactating women. Patients interfere with a loss to follow up.

Design outcomes

Primary

MeasureTime frame
Reduction in low density lipoprotein cholesterolTimepoint: 3,6,12 months—

Secondary

MeasureTime frame
Gained Knowledge on dyslipidemia or hyperlipidemia and its treatmentTimepoint: 3,6,12 months—

Countries

India

Contacts

Public ContactDr Ramesh Bhandari

KLE College of Pharmacy Belagavi

msganachari@gmail.com9448634457

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026